Organ-on-a-chip technology for nanoparticle research

Nano Convergence

Dan Dongeun Huh¹  Shawn Kang¹  Sunghee Estelle Park¹ 

[1] Department of Bioengineering, University of Pennsylvania;

关键词: Organ-on-chip;    Microfluidics;    Microphysiological systems;    Nanoparticles;    Nanomedicine;    Nanotherapeutics;   

DOI  :  10.1186/s40580-021-00270-x

来源: DOAJ

【 摘 要 】

Abstract The last two decades have witnessed explosive growth in the field of nanoengineering and nanomedicine. In particular, engineered nanoparticles have garnered great attention due to their potential to enable new capabilities such as controlled and targeted drug delivery for treatment of various diseases. With rapid progress in nanoparticle research, increasing efforts are being made to develop new technologies for in vitro modeling and analysis of the efficacy and safety of nanotherapeutics in human physiological systems. Organ-on-a-chip technology represents the most recent advance in this effort that provides a promising approach to address the limitations of conventional preclinical models. In this paper, we present a concise review of recent studies demonstrating how this emerging technology can be applied to in vitro studies of nanoparticles. The specific focus of this review is to examine the use of organ-on-a-chip models for toxicity and efficacy assessment of nanoparticles used in therapeutic applications. We also discuss challenges and future opportunities for implementing organ-on-a-chip technology for nanoparticle research.

【 授权许可】

Unknown